R 299.9832 Hazardous waste pharmaceuticals; shipping potentially creditable hazardous waste pharmaceuticals from a healthcare facility or reverse distributor to a reverse distributor.

Rule 832. (1) A healthcare facility or a reverse distributor that transports or offers for transport potentially creditable hazardous waste pharmaceuticals off-site to a reverse distributor shall comply with all applicable DOT regulations in 49 CFR part 171 to 180 for any potentially creditable hazardous waste pharmaceutical that meets the definition of hazardous material in 49 CFR 171.8. For purposes of the DOT regulations, a material is considered a hazardous waste if it is subject to the hazardous waste manifest requirements in part 3 of these rules. Because a potentially creditable hazardous waste pharmaceutical does not require a manifest, it is not considered hazardous waste. (2) On receipt of each shipment of potentially creditable hazardous waste pharmaceuticals, the receiving reverse distributor shall provide paper or electronic confirmation to the healthcare facility or reverse distributor that initiated the shipment that the shipment has arrived at its destination and is under the custody and control of the reverse distributor. (3) If a healthcare facility or reverse distributor initiates a shipment of potentially creditable hazardous waste pharmaceuticals to a reverse distributor and does not receive delivery confirmation within 35 calendar days from the date that the shipment of potentially creditable hazardous waste pharmaceuticals was sent, the healthcare facility or reverse distributor that initiated the shipment shall contact the carrier and the intended reverse distributor promptly to report that the delivery confirmation was not received and determine the status of the potentially creditable hazardous waste pharmaceuticals. (4) A healthcare facility or reverse distributor that sends potentially creditable hazardous waste pharmaceuticals to a foreign destination shall comply with R 299.9314, except the manifesting requirement of 40 CFR 262.83(c), in addition to subrules (1) to (3) of this rule. (5) Any person that imports potentially creditable hazardous waste pharmaceuticals into the United States is subject to subrules (1) to (3) of this rule instead of R 299.9314. Immediately after the potentially creditable hazardous waste pharmaceuticals enter the United States, they are subject to all applicable requirements of R 299.9824 to R 299.9833.